EUVIMEDEUVIMED entdecken
Open Access

Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy

Lie Ma iD, Yu Han iD, Zixin Chen iD, Xuan Liu iD, Yu Wang iD, Zhiyao Wang iD, Weifang Xiang iD, Lei Li iD, Xin Jin iD, Jingyao Hou iD, Yue Li iD, Baiqu Huang iD und 2 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adw1553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Lie Ma und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun 130024, China. Hauptthemen laut MEDLINE: Pyroptosis, Cellular Senescence, Small Cell Lung Carcinoma, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy-induced different cell fates play crucial roles in cancer treatment outcomes; however, the cross-talk between the cell fates during cancer recurrence remains unclear. Here, we found that the transition from cellular senescence to pyroptosis promoted small cell lung cancer (SCLC) recurrence after cisplatin and etoposide treatment. Parts of the senescent SCLC cells induced by chemotherapy showed positive cytoplasmic chromatin fragments (CCFs), and CCFs activated the ubiquitin-editing enzyme A20, which stabilized NLRP3 through its deubiquitinating activity, resulting in senescent cells undergoing pyroptosis. Subsequent inflammatory factors [such as interleukin-1 (IL-1)] released by pyroptosis promoted the acquisition of stem-like properties in CCF-negative senescent cells, ultimately promoting tumor recurrence. We also found that a combination of IL-1 receptor antagonist anakinra with chemotherapy delayed recurrence of SCLC, suggesting previously unidentified therapeutic strategies for SCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisCellular SenescenceSmall Cell Lung CarcinomaLung NeoplasmsNeoplasm Recurrence, LocalChromatinCisplatinEtoposideAntineoplastic Agents, PhytogenicInterleukin 1 Receptor Antagonist ProteinXenograft Model Antitumor AssaysMice, NudeMaleAnimalsMiceMice, Inbred BALB C

Substanzen

ChromatinCisplatinEtoposideAntineoplastic Agents, PhytogenicInterleukin 1 Receptor Antagonist Protein

Autor:innen und Institutionen

  • The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun 130024, China.
  • School of life science, Northeast Normal University, Changchun 130024, China.
  • Medical Oncology Department, Affiliated Tumor Hospital, Harbin Medical University, Harbin 150001, China.

ORCID-Profile: Lie Ma, Yu Han, Zixin Chen, Xuan Liu, Yu Wang, Zhiyao Wang, Weifang Xiang, Lei Li, Xin Jin, Jingyao Hou, Yue Li, Baiqu Huang, Jun Lu, Yu Zhang

Zitieren

APA

Ma, L., Han, Y., Chen, Z., Liu, X., Wang, Y., Wang, Z., Xiang, W., Li, L., Jin, X., Hou, J., Li, Y., Huang, B., Lu, J., & Zhang, Y. (2025). Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy. Science Advances. https://doi.org/10.1126/sciadv.adw1553

Vancouver

Ma L, Han Y, Chen Z, Liu X, Wang Y, Wang Z, et al. Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy. Science Advances. 2025. doi:10.1126/sciadv.adw1553

BibTeX
@article{Ma2025,
  author = {Ma, Lie and Han, Yu and Chen, Zixin and Liu, Xuan and Wang, Yu and Wang, Zhiyao and Xiang, Weifang and Li, Lei and Jin, Xin and Hou, Jingyao and Li, Yue and Huang, Baiqu and Lu, Jun and Zhang, Yu},
  title = {Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adw1553}
}
Kostenlos starten →